Healthy donors vaccinated against HPV to help fight cancer in loved ones
NCT ID NCT06508138
First seen Mar 09, 2026 · Last updated May 13, 2026 · Updated 10 times
Summary
This study enrolls healthy relatives of patients with advanced HPV16-related cancer. Donors receive a therapeutic HPV vaccine to boost their immune cells against the virus. Their blood cells are then used for a bone marrow transplant or immune cell infusion in the cancer patient. The goal is to safely improve the patient's ability to fight the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, 21287, United States
Conditions
Explore the condition pages connected to this study.